|Bid||6.17 x 1000|
|Ask||6.24 x 1000|
|Day's Range||6.02 - 6.34|
|52 Week Range||4.00 - 8.60|
|Beta (5Y Monthly)||0.76|
|PE Ratio (TTM)||1.00|
|Earnings Date||Feb 07, 2024 - Feb 12, 2024|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Nov 16, 2023|
|1y Target Est||23.33|
Subscribe to Yahoo Finance Plus to view Fair Value for MEIP
In this piece, we will take a look at the 11 cheapest stocks with the biggest upside. If you want to skip our introduction to stock valuation and recent market news, then take a look at 5 Cheapest Stocks With Biggest Upside. Identifying the right stocks to invest in is a science that involves evaluating […]
AstraZeneca's (AZN) capivasertib gets approval in combination with Faslodex for HR-positive, HER2-negative metastatic breast cancer.
Ironwood's (IRWD) third-quarter 2023 earnings miss estimates, while revenues beat the same. Linzess collaboration revenues drive the top line.